Morgantown, WV2 Active Studies

Myalgic Encephalomyelitis Clinical Trials in Morgantown, WV

Find 2 actively recruiting myalgic encephalomyelitis clinical trials in Morgantown, WV. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
750
Enrolling

Recruiting Myalgic Encephalomyelitis Studies in Morgantown

About Myalgic Encephalomyelitis Clinical Trials in Morgantown

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 2 myalgic encephalomyelitis clinical trials recruiting participants in Morgantown, WV. These studies are seeking a combined 750 participants. Research is being sponsored by Arthrex, Inc., West-Ward Pharmaceutical. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Morgantown — FAQ

Are there myalgic encephalomyelitis clinical trials in Morgantown?

Yes, there are 2 myalgic encephalomyelitis clinical trials currently recruiting in Morgantown, WV. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Morgantown?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Morgantown research site will contact you about next steps.

Are clinical trials in Morgantown free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Morgantown studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 2 active trials in Morgantown are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated July 18, 2026 from ClinicalTrials.gov